Abstract 193: Lapaquistat Acetate, A Novel Squalene Synthase Inhibitor, Co-administered with Atorvastatin Reduces Plasma Lipids and C-Reactive Protein Levels in Subjects with Prima... von Davidson, Michael H, Maki, Kevin C, Zavoral, James H, Yu, Shawn, Popovici, Clement, Price, Graham D

Volltext

Abstract #25: Pioglitazone Plus Sulfonylurea Reduces Circulating Very-Low-Density Lipoproteins and Free Fatty Acids in Subjects with Type 2 Diabetes Mellitus Poorly Controlled with... von Rosenblatt, Sid, Cichy, Stephen, Popovici, Clement, Zhang, Jeff, Perez, Alfonso, Murray, Frederick T.

Volltext

Abstract #27: Pioglitazone Plus Metformin Reduces Circulating Very-Low-Density Lipoproteins and Free Fatty Acids in Subjects with Type 2 Diabetes Mellitus Poorly Controlled with Me... von Phillips, Lawrence S., Murray, Frederick T., Cichy, Stephen, Popovici, Clement, Zhang, Jeff, Perez, Alfonso

Volltext

Pioglitazone Plus Sulfonylurea Reduces Circulating Very-Low-Density Lipoproteins and Free Fatty Acids in Subjects With Type 2 Diabetes Mellitus Poorly Controlled With Sulfonylurea... von Rosenblatt, Sid, Cichy, Stephen, Popovici, Clement, Zhang, Jeff, Perez, Alfonso, Murray, Frederick T

Volltext

Pioglitazone Plus Metformin Reduces Circulating Very-Low-Density Lipoproteins and Free Fatty Acids in Subjects With Type 2 Diabetes Mellitus Poorly Controlled With Metformin Alone von Phillips, Lawrence S, Murray, Frederick T, Cichy, Stephen, Popovici, Clement, Zhang, Jeff, Perez, Alfonso

Volltext

Introduction au numéro spécial von Popovici, Alexandra, Clément-Fontaine, Mélanie, Gidrol-Mistral, Gaële

Volltext